Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Lightstone Value Plus REIT IV, Inc.Lightstone Value Plus REIT IV Reports Q1 2025 Revenue Growth to $5.1 Million, Net Loss Improves
Vivani Medical, Inc.Vivani Medical Reports $6.3 Million Net Loss in Q1 2025, Focuses on Biopharmaceutical Initiatives
Star Equity Holdings, Inc.Hudson Global Reports $31.9 Million Revenue in Q1 2025, Down 6% Year-Over-Year
BayFirst Financial Corp.BayFirst Financial Corp. Reports $335,000 Net Loss in Q1 2025 Amid Decreased Noninterest Income
Metagenomi Therapeutics, Inc.Metagenomi Reports Q1 2025 Financial Results, Collaboration Revenue Drops to $4.1 Million
Carisma Therapeutics Inc.Carisma Therapeutics Reports $9.3 Million Net Loss in Q1 2025, Focuses on Strategic Alternatives
TWFG, Inc.TWFG, Inc. Reports $6.9 Million Net Income and $53.8 Million Revenue in Q1 2025
Lyell Immunopharma, Inc.Lyell Immunopharma Reports Revenue Increase and Reduced Net Loss in Q1 2025
SilverBox Corp IVSilverBox Corp IV Reports $1.93 Million Net Income in Q1 2025
IRIDEX CORPIRIDEX Reports 1.1% Revenue Growth and Reduced Net Loss in Q1 FY 2025
Intuitive Machines, Inc.Intuitive Machines Reports $62.5 Million Revenue in Q1 2025, Net Income Turnaround
MEDICINOVA INCMediciNova Reports Q1 2025 Financial Results with $2.86 Million Net Loss
SCIENTIFIC INDUSTRIES INCScientific Industries Reports $1.78 Million Net Loss and Revenue Decline for Q1 2025
TherapeuticsMD, Inc.TherapeuticsMD Reports 25.6% Revenue Growth and $653,000 Net Loss in Q1 2025
Annovis Bio, Inc.Annovis Bio Reports $5.5 Million Net Loss in Q1 2025, Cash Balance Increases to $22.2 Million
SEAFARER EXPLORATION CORPSeafarer Exploration Corp. Reports Q1 2025 Financial Results with Reduced Net Loss
Acumen Pharmaceuticals, Inc.Acumen Pharmaceuticals Reports Increased Net Loss of $28.8 Million in Q1 2025
SIEBERT FINANCIAL CORPSiebert Financial Corp. Reports Revenue Growth to $28.9 Million in Q1 2025
Verrica Pharmaceuticals Inc.Verrica Pharmaceuticals Reports Q1 2025 Financial Results with Revenue Decline and Improved Losses
Anebulo Pharmaceuticals, Inc.Anebulo Pharmaceuticals Reports $1.68 Million Net Loss and Strategic Shift to IV Selonabant Development
CYBERLOQ TECHNOLOGIES, INC.CyberloQ Technologies Reports $0 Revenue and Increased Losses in Q1 2025
ICAD INCiCAD Reports $4.9 Million Revenue in Q1 2025, Faces Decline in Services Revenue
1606 CORP.1606 Corp. Reports Zero Revenue and Continued Net Loss in Q1 2025
DiaMedica Therapeutics Inc.DiaMedica Therapeutics Reports $7.7 Million Net Loss in Q1 2025
Seer, Inc.Seer, Inc. Reports 37% Revenue Growth to $4.2 Million in Q1 2025